Researchers will investigate the effectiveness of a new anticoagulant drug to prevent abnormal and deadly blood clotting complications in cats with heart disease.

Researchers will investigate the effectiveness of the antiviral drug famciclovir to treat and control infectious upper-respiratory disease associated with feline herpesvirus in shelter cats.

Researchers will investigate the effectiveness of a contraceptive vaccine to manage overpopulation of free-roaming cats.

Researchers will investigate an economical, rapid-imaging method to see if cancer cells are left behind following surgical removal of sarcomas in cats.

Researchers will investigate the use of a novel dietary supplement, avocado extract, to prevent and treat obesity in cats without the need for food restriction.

Researchers will investigate whether viral mutations associated with feline infectious peritonitis are valuable and effective diagnostic targets.

Researchers will investigate a vaccine strategy against feline enteric coronavirus, a common, nonlethal virus that can mutate into feline infectious peritonitis virus.

Researchers will investigate genetic changes that occur in the feline enteric coronavirus that contribute to the development of feline infectious peritonitis, an incurable and fatal disease in cats.

Researchers will conduct a clinical trial to investigate the effectiveness of a novel antiviral drug in client-owned cats with naturally occurring feline infectious peritonitis as well as drug resistance that may occur during treatment.

Researchers will investigate if amoeba (single-celled animals) living in soils in endemic plague areas can serve as reservoir hosts for Yersinia pestis (the causative agent for bubonic plague) and if amoeba are involved in plague disease cycles.